Qianhui Shang | Cancer Genetics | Best Researcher Award

Dr. Qianhui Shang | Cancer Genetics | Best Researcher Award

Sichuan University | China

Author Profile

Scopus

Orcid ID

🌟 Biography of Qianhui Shang, PhD 🌟

đź“š EARLY ACADEMIC PURSUITS

Dr. Qianhui Shang's journey into the field of oral medicine began with her enrollment at the School of Stomatology, Dalian Medical University (2013-2018), where she completed her Bachelor's degree. Her passion for understanding oral diseases deepened, leading her to pursue an MDDS at Sichuan University, West China Hospital of Stomatology (2018-2021), one of the most prestigious dental programs in China. To further enhance her knowledge and contribute to academic research, she undertook a Ph.D. at the same institution, specializing in oral potentially malignant diseases (2019-2023).

👩‍⚕️ PROFESSIONAL ENDEAVORS

With a solid foundation in clinical dentistry and a passion for research, Dr. Shang has worked as a clinician and researcher focusing on oral mucosal diseases and oral potentially malignant disorders (OPMDs). Her work bridges clinical practices with cutting-edge research to improve patient outcomes, highlighting the translational impact of her expertise.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS

Dr. Shang has contributed extensively to the understanding of:

  1. Mechanisms of Oral Potentially Malignant Diseases (OPMDs)
    She has investigated the underlying pathophysiology and cellular processes that lead to the transformation of oral tissues into malignancies.
  2. Clinical Research in Oral Medicine
    Her research also explores innovative diagnostic and therapeutic strategies for managing oral mucosal diseases.

Her commitment to excellence in both research and practice demonstrates her dedication to advancing the field.

🌍 IMPACT AND INFLUENCE

Dr. Shang's work is instrumental in highlighting the importance of early diagnosis and prevention of oral cancers. Her research findings have the potential to influence clinical guidelines for managing oral potentially malignant conditions, contributing to improved patient outcomes globally.

đź“– ACADEMIC CITATIONS

Although details about specific publications are not provided, her research on the mechanisms of oral diseases likely includes articles in high-impact journals. Her academic endeavors enhance her credibility as a leading figure in the domain of oral medicine.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Shang aspires to make lasting contributions to the field of oral medicine through her research, clinical practice, and mentorship. Her future vision involves:

  • Expanding the understanding of the biological underpinnings of oral potentially malignant diseases.
  • Establishing international collaborations to integrate innovative diagnostic tools into clinical practice.
  • Mentoring young scholars passionate about oral health to continue advancing this critical field.

✨ ABOUT DR. QIANHUI SHANG

  • Uygur origin, Xinjiang province.
  • Passionate about unraveling the complexities of oral mucosal diseases.
  • Dedicated to improving the management of oral diseases through clinical and research-based innovation.

📑NOTABLE PUBLICATIONS 

"Hydroxychloroquine is effective in oral lichen planus: A multicenter, randomized, controlled trial" 

  • Authors: Xie, Y. , Xu, H. , Li, C. , Zhou, Y. , Chen, Q. Oral
  • Journal: Diseases
  • Year: 2024

"Humoral immune disorders affect clinical outcomes of oral lichen planus" 

  • Authors: Qing, M. , Yang, D. , Shang, Q. , Xu, H. , Chen, Q.
  • Journal: Oral Diseases
  • Year: 2024

"The clinical implication and translational research of OSCC differentiation" 

  • Authors: Shang, Q. , Jiang, Y. , Wan, Z. , Chen, Q. , Xu, H.
  • Journal: British Journal of Cancer
  • Year: 2024

"Periodontitis and the risk of all-cause and cause-specific mortality among US adults with diabetes: A population-based cohort study" 

  • Authors: Li, W. , Peng, J. , Shang, Q. , Zhao, H. , Xu, H.
  • Journal: Journal of Clinical Periodontology
  • Year: 2024

"Angelicin inhibits cell growth and promotes apoptosis in oral squamous cell carcinoma by negatively regulating DUSP6/cMYC signaling pathway" 

  • Authors: Liu, N. , Li, C. , Shang, Q. , Xie, L. , Chen, Q.
  • Journal: Experimental Cell Research
  • Year: 2023

William Hanna Kutteh | Chromosomal Abnormalities | Excellence in Research 

Prof Dr. William Hanna Kutteh | Chromosomal Abnormalities | Excellence in Research 

University of Tennessee HSC and Baptist Women's Hospital | Unites States

Author Profile

Scopus

Google Scholar

🌟 Biography of William Hanna Kutteh, MD, PhD, HCLD, CC 🌟

William Hanna Kutteh is a distinguished physician, scientist, and educator with an exceptional career in reproductive endocrinology, obstetrics, and gynecology. His contributions span across academic research, clinical excellence, and education, solidifying his legacy as a pioneer in reproductive health.

🏛️ EARLY ACADEMIC PURSUITS

William Hanna Kutteh embarked on his academic journey at Wake Forest University, earning a Bachelor of Arts in Biology with a minor in Chemistry (1971-1975). His keen interest in immunology led him to pursue graduate studies at Duke University, where he took advanced courses in immunology under the mentorship of Dr. Jeff Dawson (1975-1978).

He furthered his research with a Ph.D. in Molecular Cell Biology and Immunology from the University of Alabama at Birmingham (1978-1981), mentored by Dr. Jiri Mestecky. Following this, he achieved his MD at the Wake Forest University School of Medicine (1981-1985).

đź©ş PROFESSIONAL ENDEAVORS

Key Positions

Dr. Kutteh has held prominent positions across leading institutions:

  • Founding Partner & Director at the Fertility Associates of Memphis
  • Professor of Obstetrics and Gynecology, University of Tennessee Health Sciences Center
  • Clinical Professor, Vanderbilt University Medical Center
  • Consulting Gynecologist, St. Jude Children’s Research Hospital, where he founded the Fertility Preservation Program

Special Roles

  • Director of Reproductive Endocrinology and Infertility at Baptist Memorial Hospital
  • Director of Resident Research Program, fostering the next generation of reproductive specialists
  • Director of EMIGS Simulation Training, advancing minimally invasive gynecologic surgery training

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHROMOSOMAL ABNORMALITIES

Dr. Kutteh’s research encompasses:

  1. Reproductive Immunology: Exploring immunological causes of recurrent pregnancy loss.
  2. Fertility Preservation: Pioneering techniques for cancer patients.
  3. Endocrine Disorders: Advancing treatments in reproductive endocrinology and infertility.
  4. Minimally Invasive Surgery: Innovating gynecological surgical techniques.

His dedication to translational medicine bridges the gap between laboratory research and clinical application, improving patient outcomes.

🌍 IMPACT AND INFLUENCE

Dr. Kutteh has significantly impacted:

  • Patient Care: As a reproductive endocrinologist, he has transformed the lives of countless families.
  • Medical Education: Training residents and fellows in cutting-edge reproductive techniques.
  • Research: Leading groundbreaking studies funded by the NIH, such as a prestigious R01 grant from the National Institutes of Child Health and Human Development (1995-1999).

đź“š ACADEMIC CITATIONS

Dr. Kutteh's scholarly contributions include:

  • Numerous peer-reviewed publications in high-impact journals.
  • Regular faculty roles at national and international conferences such as ASRM, ESHRE, and FASEB, where his expertise in early pregnancy and immunology is widely sought after.
  • Recognition by Newsweek and US News & World Report as one of the top reproductive endocrinologists in America.

🏅 HONORS AND AWARDS

Dr. Kutteh's accolades include:

  • America’s Top Doctors by Castle Connolly (1996-2022)
  • Top Reproductive Endocrinologist by US News & World Report (2012)
  • Louie C. Henry Faculty Award for excellence in clinical teaching (2024)

He has also received numerous Sigma Xi Research Awards and service awards from professional societies, such as the American Society for Reproductive Medicine (ASRM).

đź’ˇ LEGACY AND FUTURE CONTRIBUTIONS

Dr. Kutteh’s legacy is marked by his dual commitment to advancing reproductive medicine and mentoring future leaders in the field. His ongoing work in fertility preservation, reproductive immunology, and minimally invasive surgery ensures his enduring influence.

As a visionary, he continues to push the boundaries of reproductive health through research, innovation, and education, shaping a brighter future for patients and practitioners alike.

📑NOTABLE PUBLICATIONS 

"Response: Would surgical retrieval of product of conception for the purpose of genetic analysis increase the risk of intra uterine adhesions?" 

  • Authors: Kutteh, W.H. , Maisenbacher, M. , Dahdouh, E.M.
  • Journal: Reproductive BioMedicine Online
  • Year: 2024

"Cell-Free DNA Analysis of Fetal Aneuploidies in Early Pregnancy Loss" 

  • Authors: Kutteh, W.H. , Miller, C.E. , Park, J.K. , Bhatt, S. , Keefe, D.L.
  • Journal: Journal of Clinical Medicine
  • Year: 2024

"Role of genetic analysis of products of conception and PGT in managing early pregnancy loss" 

  • Authors: Kutteh, W.H. , Papas, R.S. , Maisenbacher, M.K. , Dahdouh, E.M.
  • Journal: Reproductive BioMedicine Online
  • Year: 2024

"Expanding the role of chromosomal microarray analysis in the evaluation of recurrent pregnancy loss" 

  • Authors: Eliwa, J. , Papas, R.S. , Kutteh, W.H.
  • Journal: Journal of Reproductive Immunology
  • Year: 2024

"Is it time for new guidelines for recurrent pregnancy loss integrating genetic testing of products of conception and preimplantation genetic testing?" 

  • Authors: Kutteh, W.H. , Papas, R.S. , Dahdouh, E.M.
  • Journal: Fertility and Sterility
  • Year: 2024